07.24.12
18. Toshiba
$4.6 Billion ($74.4B total)
KEY EXECUTIVES:
Atsutoshi Nishida, Chairman & Director, Toshiba Corp.
Satoshi Tsunakawa, President & CEO, Toshiba Medical Systems Corp.
Toshiya Miyaguchi, President, Toshiba America Medical Systems
Kevin Abbott, Sr. VP, CFO & Treasurer, Toshiba America Medical Systems
Donald Fowler, Sr. VP & General Manager, Toshiba America Medical Systems
Doug Ryan, VP, Marketing & Strategic Development, Toshiba America Medical Systems
Scott Goodwin, VP of Sales, Toshiba America Medical Systems
NO. OF EMPLOYEES: 210,000 (total)
GLOBAL HEADQUARTERS: Tokyo, Japan
At 137 years old, Toshiba Corp. is at the top of this list as far as venerable multinational conglomerates go. The healthcare arm of the global electronics giant Toshiba—Toshiba Medical Systems Corp.—manufacturers diagnostic imaging (cardiovascular X-rays, computed tomography imaging, magnetic resonance imaging, and ultrasound). Much of the company’s business comes out of its North American base, Toshiba America Medical Systems, in Tustin, Calif. The medical division barely is mentioned in detail in the company’s annual financial reports, but it’s certainly doing a robust business.
Overall, Toshiba Corp. net sales for the 2011 fiscal year (ended March 31, 2012) were $74.4 billion, a decrease of approximately $3.6 billion compared to the previous year’s sales. The company cited appreciation of the yen, the Japan earthquake and floods in Thailand as major factors impacting financial performance for the year. Operating income was $2.5 billion, a decrease of roughly $400 million. Net income for the year was $1.9 billion, a decrease of $523 million.
The company reported that its medical sales division inked “steady increases” in business for FY11. The company had $4.4 billion yen in sales, an increase of 23 percent (in yen).
Toshiba America Medical Systems made a number of key strategic hires throughout the fiscal year.
In April last year, two key hires were made. Stephen Bumb was named director of the company’s X-ray Vascular Business Unit. As the new director, he is responsible for implementing strategic and tactical marketing plans to drive growth. He also interfaces with the global business unit at Toshiba Medical Systems Corporation to communicate the needs and requirements of the U.S. market. Prior to joining Toshiba, Bumb was the marketing director for Edwards Lifesciences Critical Care in Irvine, Calif. In his time there, he was key in the development and operation of a comprehensive, nationwide clinician education program, the re-engineering of the company’s sales training program and development of a new sales channel, contributing to a 30 percent annual growth for two new market development-stage products. He has also held executive positions at Imagyn Medical Technologies and Vascular Control Systems Inc.
At the end of the month, Donald L. Fowler was brought on board as general manager and senior vice president. In this role, Fowler is responsible for driving the growth of Toshiba’s multi-modality business in the United States. He oversees sales, marketing, service, finance, human resources and information technology functions.
“Mr. Fowler has had an impressive career in diagnostic imaging,” said Toshiya Miyaguchi, president, TAMS. “His multi-functional, multi-modality experience, as well as his history leading a $2.5 billion dollar business, make him a great fit for this position.”
Prior to Toshiba, Fowler held the position of vice president of MR Business Unit at Siemens Medical Solutions USA.
In June, the company announced that Guy Poloni, Ph.D., had been named product manager for the Vantage Titan 3T MR system. In his new position, Poloni develops and implements product marketing strategies and programs for the system, and is helping to launch the product, which at the time of his hiring was pending 510(k) clearance. Prior to joining Toshiba, Poloni worked as Sequence Development Unit Director at Buffalo Neuroimaging Center at The Jacobs Neurological Institute in Buffalo, N.Y. Poloni has received numerous research fellowships and has co-authored multiple articles for medical journals, such as The Neurologist and European Journal of Paediatric Neurology. He holds a doctorate and a master’s degree in theoretical physics and a bachelor’s degree in physics from the University of Milan in Italy.
In August, Toshiba America Medical Systems named Scott Goodwin vice president of Sales. He oversees CT, MR, X-ray/vascular and ultrasound sales field operations, sales and customer training and applications. Goodwin joined Toshiba after two years with Philips Healthcare as general manager, Nuclear Medicine Business. Prior to that, he worked for Siemens Medical Solutions as general manager, Western Zone Sales. During his nearly 20 years at Siemens, Goodwin held the positions of vice president, CT Business Management; national sales director, PET/CT systems; as well as several other sales-related positions.
What’s immediately notable about Toshiba Medical Systems is the firm’s steady stream of new product introductions. And FY11 was no different.
On April 14, 2011, Toshiba introduced upgrades across its ultrasound product line. The recently added features available on the Aplio XG, Aplio MX, Xario XG and Viamo systems include Auto IMT, 4-D imaging improvements and workflow protocol enhancements. Additional upgrades to the Viamo include ApliPure, TissuePure imaging and DICOM structured reporting. Auto-IMT can determine the thickness of the near and far arterial walls from three segments of the carotid artery at an optimal angle of incidence and two complementary planes, according to the company. Auto-IMT traces the two complementary planes automatically and calculates the distance between them in order to help with early detection and monitoring of cardiovascular disease. Auto-IMT uses the collected images following the American Society of Echocardiography’s consensus statement for the diagnosis.
During biopsies, 4-D imaging allows for more accurate guidance of the biopsy needle. Precise visualization of the needle path creates safer exams and reduces potential complications. Workflow enhancements include protocols that standardize image output and increase exam efficiency by reducing the number of tasks per exam, according to the company. Sonographers have the ability to add custom annotations and reshuffle images as well as being able to exit the protocol when additional images are required and re-enter at the same place to continue the protocol with just the click of a button.
Upgrades to the Viamo include ApliPure, TissuePure Imaging and DICOM structured reporting. The new upgrades enable clinicians to perform advanced exams with greater image definition and clinical accuracy without compromising on patient access, making it well-suited for high-end radiology, vascular, and OB/GYN exams and procedures at patients’ bedsides. A new 40-centimeter depth setting allows improved imaging of patients that traditionally have been difficult to image.
In August, the company rolled out the U.S. Food and Drug Administration (FDA)-cleared HDR-08A Imaging System that offers Toshiba’s Kalare R&F technology with a new user interface and more advanced image processing, increasing the dynamic range of fluoroscopy. With these new system features, according to the company, clinicians can obtain more information from the images, resulting in quicker, more accurate patient diagnoses.
In September, the company’s M-Power magnetic resonance (MR) imaging interface received FDA clearance. M-Power is a customizable MR system user interface designed to allow users to streamline and accelerate scanning processes and enhance diagnoses. M-Power is available for use on Toshiba’s Vantage Atlas, Vantage Titan 1.5 and Titan 3T MR systems.
November brought with it FDA clearance of the Aplio 300 ultrasound system.
“The Aplio 300 combines powerful visualization capabilities, workflow automation tools and better ergonomics for more accurate diagnoses and better patient throughput,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “The system meets a variety of needs, making it an essential ultrasound system for today’s healthcare environment.” The system is smaller and designed for high-volume ultrasound exams, including radiology, OB/GYN and cardiovascular.
Also introduced in November of fiscal 2011 was the Vantage Titan 1.5T MR Series.
The start of 2012 included FDA clearance of the Aquilion Prime CT system, the latest addition to the Aquilion CT product line and part of Toshiba’s “ONE Family” of CT scanners. The system can generate 160 unique “slices” per rotation, enhancing imaging. The Aquilion Prime was designed for healthcare facilities that need to perform a wide variety of advanced clinical examinations and produce high-quality clinical images with reduced radiation exposure.
“The combination of the 0.35-second gantry rotation speed and the state-of-the-art reconstruction technology allows many examinations to be performed and reconstructed in mere seconds, improving patient care and overall departmental efficiency,” said Joseph Cooper, director, CT Business Unit, Toshiba. “That, along with standard patient safety features … helps clinicians acquire quality images while attempting to minimize radiation dose as much as possible.”
Though clearly busy on the new-product front, Toshiba executives weren’t too busy to look for some inorganic growth.
In April 2011, the company purchased Minneapolis, Minn.-based Vital Images Inc. in an all cash deal for $273 million ($18.75 per share).
“After a decade-long successful partnership spanning more than 50 countries, [Terumo] is taking the partnership to the next level,” said Satoshi Tsunakawa, CEO of Toshiba Medical Systems Corp. “We have enormous respect for Vital’s products, pipeline and people, and look forward to working with their highly skilled team to enhance clinical value for patients throughout the world.”
Established in 1998, Vital Images makes of advanced visualization and analysis software for physicians and healthcare specialists. The company’s software enables the visualization and analysis of 2-D, 3-D and 4-D images of anatomy and physiological function using computed tomography and magnetic resonance scan data, offering medical specialists time-saving, Web-accessible tools for greater productivity.
$4.6 Billion ($74.4B total)
KEY EXECUTIVES:
Atsutoshi Nishida, Chairman & Director, Toshiba Corp.
Satoshi Tsunakawa, President & CEO, Toshiba Medical Systems Corp.
Toshiya Miyaguchi, President, Toshiba America Medical Systems
Kevin Abbott, Sr. VP, CFO & Treasurer, Toshiba America Medical Systems
Donald Fowler, Sr. VP & General Manager, Toshiba America Medical Systems
Doug Ryan, VP, Marketing & Strategic Development, Toshiba America Medical Systems
Scott Goodwin, VP of Sales, Toshiba America Medical Systems
NO. OF EMPLOYEES: 210,000 (total)
GLOBAL HEADQUARTERS: Tokyo, Japan
At 137 years old, Toshiba Corp. is at the top of this list as far as venerable multinational conglomerates go. The healthcare arm of the global electronics giant Toshiba—Toshiba Medical Systems Corp.—manufacturers diagnostic imaging (cardiovascular X-rays, computed tomography imaging, magnetic resonance imaging, and ultrasound). Much of the company’s business comes out of its North American base, Toshiba America Medical Systems, in Tustin, Calif. The medical division barely is mentioned in detail in the company’s annual financial reports, but it’s certainly doing a robust business.
Overall, Toshiba Corp. net sales for the 2011 fiscal year (ended March 31, 2012) were $74.4 billion, a decrease of approximately $3.6 billion compared to the previous year’s sales. The company cited appreciation of the yen, the Japan earthquake and floods in Thailand as major factors impacting financial performance for the year. Operating income was $2.5 billion, a decrease of roughly $400 million. Net income for the year was $1.9 billion, a decrease of $523 million.
The company reported that its medical sales division inked “steady increases” in business for FY11. The company had $4.4 billion yen in sales, an increase of 23 percent (in yen).
Toshiba America Medical Systems made a number of key strategic hires throughout the fiscal year.
In April last year, two key hires were made. Stephen Bumb was named director of the company’s X-ray Vascular Business Unit. As the new director, he is responsible for implementing strategic and tactical marketing plans to drive growth. He also interfaces with the global business unit at Toshiba Medical Systems Corporation to communicate the needs and requirements of the U.S. market. Prior to joining Toshiba, Bumb was the marketing director for Edwards Lifesciences Critical Care in Irvine, Calif. In his time there, he was key in the development and operation of a comprehensive, nationwide clinician education program, the re-engineering of the company’s sales training program and development of a new sales channel, contributing to a 30 percent annual growth for two new market development-stage products. He has also held executive positions at Imagyn Medical Technologies and Vascular Control Systems Inc.
At the end of the month, Donald L. Fowler was brought on board as general manager and senior vice president. In this role, Fowler is responsible for driving the growth of Toshiba’s multi-modality business in the United States. He oversees sales, marketing, service, finance, human resources and information technology functions.
“Mr. Fowler has had an impressive career in diagnostic imaging,” said Toshiya Miyaguchi, president, TAMS. “His multi-functional, multi-modality experience, as well as his history leading a $2.5 billion dollar business, make him a great fit for this position.”
Prior to Toshiba, Fowler held the position of vice president of MR Business Unit at Siemens Medical Solutions USA.
In June, the company announced that Guy Poloni, Ph.D., had been named product manager for the Vantage Titan 3T MR system. In his new position, Poloni develops and implements product marketing strategies and programs for the system, and is helping to launch the product, which at the time of his hiring was pending 510(k) clearance. Prior to joining Toshiba, Poloni worked as Sequence Development Unit Director at Buffalo Neuroimaging Center at The Jacobs Neurological Institute in Buffalo, N.Y. Poloni has received numerous research fellowships and has co-authored multiple articles for medical journals, such as The Neurologist and European Journal of Paediatric Neurology. He holds a doctorate and a master’s degree in theoretical physics and a bachelor’s degree in physics from the University of Milan in Italy.
In August, Toshiba America Medical Systems named Scott Goodwin vice president of Sales. He oversees CT, MR, X-ray/vascular and ultrasound sales field operations, sales and customer training and applications. Goodwin joined Toshiba after two years with Philips Healthcare as general manager, Nuclear Medicine Business. Prior to that, he worked for Siemens Medical Solutions as general manager, Western Zone Sales. During his nearly 20 years at Siemens, Goodwin held the positions of vice president, CT Business Management; national sales director, PET/CT systems; as well as several other sales-related positions.
What’s immediately notable about Toshiba Medical Systems is the firm’s steady stream of new product introductions. And FY11 was no different.
On April 14, 2011, Toshiba introduced upgrades across its ultrasound product line. The recently added features available on the Aplio XG, Aplio MX, Xario XG and Viamo systems include Auto IMT, 4-D imaging improvements and workflow protocol enhancements. Additional upgrades to the Viamo include ApliPure, TissuePure imaging and DICOM structured reporting. Auto-IMT can determine the thickness of the near and far arterial walls from three segments of the carotid artery at an optimal angle of incidence and two complementary planes, according to the company. Auto-IMT traces the two complementary planes automatically and calculates the distance between them in order to help with early detection and monitoring of cardiovascular disease. Auto-IMT uses the collected images following the American Society of Echocardiography’s consensus statement for the diagnosis.
During biopsies, 4-D imaging allows for more accurate guidance of the biopsy needle. Precise visualization of the needle path creates safer exams and reduces potential complications. Workflow enhancements include protocols that standardize image output and increase exam efficiency by reducing the number of tasks per exam, according to the company. Sonographers have the ability to add custom annotations and reshuffle images as well as being able to exit the protocol when additional images are required and re-enter at the same place to continue the protocol with just the click of a button.
Upgrades to the Viamo include ApliPure, TissuePure Imaging and DICOM structured reporting. The new upgrades enable clinicians to perform advanced exams with greater image definition and clinical accuracy without compromising on patient access, making it well-suited for high-end radiology, vascular, and OB/GYN exams and procedures at patients’ bedsides. A new 40-centimeter depth setting allows improved imaging of patients that traditionally have been difficult to image.
In August, the company rolled out the U.S. Food and Drug Administration (FDA)-cleared HDR-08A Imaging System that offers Toshiba’s Kalare R&F technology with a new user interface and more advanced image processing, increasing the dynamic range of fluoroscopy. With these new system features, according to the company, clinicians can obtain more information from the images, resulting in quicker, more accurate patient diagnoses.
In September, the company’s M-Power magnetic resonance (MR) imaging interface received FDA clearance. M-Power is a customizable MR system user interface designed to allow users to streamline and accelerate scanning processes and enhance diagnoses. M-Power is available for use on Toshiba’s Vantage Atlas, Vantage Titan 1.5 and Titan 3T MR systems.
November brought with it FDA clearance of the Aplio 300 ultrasound system.
“The Aplio 300 combines powerful visualization capabilities, workflow automation tools and better ergonomics for more accurate diagnoses and better patient throughput,” said Tomohiro Hasegawa, director, Ultrasound Business Unit, Toshiba. “The system meets a variety of needs, making it an essential ultrasound system for today’s healthcare environment.” The system is smaller and designed for high-volume ultrasound exams, including radiology, OB/GYN and cardiovascular.
Also introduced in November of fiscal 2011 was the Vantage Titan 1.5T MR Series.
The start of 2012 included FDA clearance of the Aquilion Prime CT system, the latest addition to the Aquilion CT product line and part of Toshiba’s “ONE Family” of CT scanners. The system can generate 160 unique “slices” per rotation, enhancing imaging. The Aquilion Prime was designed for healthcare facilities that need to perform a wide variety of advanced clinical examinations and produce high-quality clinical images with reduced radiation exposure.
“The combination of the 0.35-second gantry rotation speed and the state-of-the-art reconstruction technology allows many examinations to be performed and reconstructed in mere seconds, improving patient care and overall departmental efficiency,” said Joseph Cooper, director, CT Business Unit, Toshiba. “That, along with standard patient safety features … helps clinicians acquire quality images while attempting to minimize radiation dose as much as possible.”
Though clearly busy on the new-product front, Toshiba executives weren’t too busy to look for some inorganic growth.
In April 2011, the company purchased Minneapolis, Minn.-based Vital Images Inc. in an all cash deal for $273 million ($18.75 per share).
“After a decade-long successful partnership spanning more than 50 countries, [Terumo] is taking the partnership to the next level,” said Satoshi Tsunakawa, CEO of Toshiba Medical Systems Corp. “We have enormous respect for Vital’s products, pipeline and people, and look forward to working with their highly skilled team to enhance clinical value for patients throughout the world.”
Established in 1998, Vital Images makes of advanced visualization and analysis software for physicians and healthcare specialists. The company’s software enables the visualization and analysis of 2-D, 3-D and 4-D images of anatomy and physiological function using computed tomography and magnetic resonance scan data, offering medical specialists time-saving, Web-accessible tools for greater productivity.
< Previous - 3M Healthcare | Zimmer - Next > |